Bone Biologics Corp

Penny Stocks Biotech Stocks Healthcare Stocks

$1.27

-0.03 (-2.27%)

As of May 16, 2:36 AM ET ·

Analyst Consensus

Strong Buy

Analysts

Moderate

Coverage

Buy 6 86%

Hold 1 14%

Sell 0 0%

Price Target

Analyst Price Target +1,568.5% upside

Low Target $14.35

Average Target $21.19

High Target $22.63

Current Price $1.27

Current
$1.27

Target
$21.19

$14.35 $21.19 avg $22.63

Scenario Analysis

Bear Case

$14.35

1,029.9%

Low target

Base Case

$21.19

+1,568.5%

Avg target

Bull Case

$22.63

+1,681.9%

High target

Risk/Reward

1.6x

Balanced

Price in Context

52-Week High

$6.75

-81.2% from high

52-Week Low

$1.05

+21.0% from low

Target vs 52W High

$21.19

+213.9% vs high

Peer Consensus — Biotechnology

Stock	Consensus	Analysts	Buy %	Target	Upside
ABBV Abbvie Inc	Strong Buy	40	75%	$257.58	+22.4%
AMGN Amgen Inc	Hold	44	48%	$190.87	-41.5%
GILD Gilead Sciences Inc	Strong Buy	39	79%	$362.68	+179.9%
VRTX Vertex Pharmaceuticals Inc	Strong Buy	39	79%	$438.34	+0.3%
REGN Regeneron Pharmaceuticals	Strong Buy	38	79%	$76.80	-89.0%
ALNY Alnylam Pharmaceuticals Inc	Strong Buy	36	75%	$102.31	-64.3%
RVMD Revolution Medicines Inc	Strong Buy	27	96%	$114.11	-21.7%
BIIB Biogen Inc	Buy	43	56%	$91.45	-52.6%